SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
17 Jul 2025 //
GLOBENEWSWIRE
ASPN releases guidelines for 60-Day PNS therapy with SPR® SPRINT
07 Jul 2025 //
GLOBENEWSWIRE
SPR Wins 4th Northeast Ohio Top Workplaces Award
30 Jun 2025 //
GLOBENEWSWIRE
SPR Publishes Chronic Shoulder Pain Outcomes Up to Five Years
28 May 2025 //
GLOBENEWSWIRE
Sprint PNS Meets Primary Endpoint in Monarch Study
21 May 2025 //
GLOBENEWSWIRE
SPR expands access to SPRINT® PNS System for Veterans
01 May 2025 //
GLOBENEWSWIRE
4-Year Follow-up on Sprint® PNS Shows Sustained Pain Relief
29 Apr 2025 //
GLOBENEWSWIRE
SPR Announces Presentation of 4 Abstracts Featuring at NANS 2025
30 Jan 2025 //
GLOBENEWSWIRE
SPR Therapeutics Named Fastest Growing Firm In N. Ohio
13 Dec 2024 //
GLOBENEWSWIRE
SPR® Therapeutics Debuts New PNS Data for Pain at ASRA Meeting
21 Nov 2024 //
GLOBENEWSWIRE
Ben Austin, CFO & COO of SPR® Therapeutics, Named to 40 Under List
18 Nov 2024 //
GLOBENEWSWIRE
SPRINT® PNS Demonstrates Robust Results in Addressing Chronic Shoulder Pain
06 Aug 2024 //
GLOBENEWSWIRE
SPR Therapeutics Shares Long-Term SPRINT PNS And MONARCH Trial Data
15 Jul 2024 //
GLOBENEWSWIRE
SPR Therapeutics Top Workplace Northeast Ohio for the Third Year in a Row
23 Jun 2024 //
GLOBENEWSWIRE
New Publication Reviewing Percutaneous PNS in Mgnt of Chronic Pain Highlights
11 Jun 2024 //
GLOBENEWSWIRE
SPR Therapeutics Publishes SPRINT PNS Impact On Postoperative Knee Pain
14 May 2024 //
GLOBENEWSWIRE
SPRINT PNS Knee Pain Relief Study Published
13 May 2024 //
GLOBENEWSWIRE
SPR® Therapeutics Announces $85 Million in Additional Funding
01 Feb 2024 //
GLOBENEWSWIRE
SPR Therapeutics Announces Extensive Set of Abstracts to be Shared at Meeting
16 Jan 2024 //
GLOBENEWSWIRE
SPR Announces Completion of Enrollment in the Trial of SPRINT® PNS System
12 Dec 2023 //
GLOBENEWSWIRE
New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
13 Nov 2023 //
GLOBENEWSWIRE
SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
22 Aug 2023 //
GLOBENEWSWIRE
SelectHealth Initiates Coverage to Support Patient Need for Effective Non-opioid
04 May 2023 //
GLOBENEWSWIRE
New SPRINT extensa XT™ with Bimodal PNS™ Offers Synergistic Treatment of Pain
25 Apr 2023 //
GLOBENEWSWIRE
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements
03 Feb 2023 //
GLOBENEWSWIRE
Real-World Retrospective Review of Axial Neck Pain Relief Peripheral Nerve St
21 Sep 2022 //
GLOBENEWSWIRE
Next Generation MicroLead 2.0 Now Available with the SPRINT® PNS System
06 Sep 2022 //
GLOBENEWSWIRE
Peripheral Nerve Stimulation Pioneer Dr. Marc Huntoon Joins SPR Therapeutics
02 Aug 2022 //
GLOBENEWSWIRE
SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022
14 Jul 2022 //
GLOBENEWSWIRE
SPR Therapeutics Announces 10,000th SPRINT PNS Procedure in Life-altering Pain
12 May 2022 //
GLOBENEWSWIRE
Real-world Study of SPRINT 60-day PNS Corroborates
06 May 2022 //
GLOBENEWSWIRE

Market Place
Sourcing Support